BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

PROCESS BIOCHEMISTRY is a premier journal published by Elsevier Science Ltd, dedicated to advancing the field of biochemistry, microbiology, and bioengineering. With an ISSN of 1359-5113 and an E-ISSN of 1873-3298, this renowned journal is recognized for its impactful contributions, as demonstrated by its Q2 ranking in Applied Microbiology and Biotechnology, Biochemistry, and Bioengineering categories as of 2023. Covering a wide array of topics since its inception in 1950, PROCESS BIOCHEMISTRY serves as a crucial platform for researchers and professionals to disseminate innovative findings and develop new insights in enzyme technology, metabolic pathways, and bioreactor design. Although the journal operates under a non-open access policy, it remains vital for those engaged in cutting-edge biochemical research and development. Located in the United Kingdom, it continues to facilitate scientific discourse and foster collaboration among industry experts and academic scholars worldwide.

The JOURNAL OF BIOSCIENCE AND BIOENGINEERING, published by the SOC BIOSCIENCE BIOENGINEERING JAPAN, is an esteemed peer-reviewed journal dedicated to advancing knowledge in the fields of applied microbiology, biotechnology, and bioengineering. With its ISSN of 1389-1723 and E-ISSN 1347-4421, this journal has been providing a platform for innovative research since its inception in 1991, maintaining its relevance through periodic updates and a scope that encompasses various aspects of bioscience and engineering. The journal boasts a notable impact factor, reflecting its contributions to the Q2 and Q3 quartiles in relevant categories as of 2023, which positions it amongst the well-regarded publications in its field. Researchers and professionals can access its rich archive through open access options, ensuring wide dissemination of pivotal studies. With its address rooted in Osaka University, Japan, the journal serves as a vital resource for scientists and scholars committed to pushing the boundaries of biosciences and engineering.

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, published by Wiley, is a renowned journal that bridges the gap between fundamental research and practical applications in the fields of biochemistry and biotechnology. With an ISSN of 0885-4513 and an E-ISSN of 1470-8744, this journal has been instrumental since its inception in 1986, focusing on diverse topics including applied microbiology, drug discovery, and process chemistry. The journal is currently recognized in various categories with impressive quartile rankings, showcasing its influence with placements in Q2 for applied microbiology, biotechnology, and biomedical engineering, among others. Researchers and professionals benefit from its comprehensive scope and critical insights into the latest advancements in these domains. Although not an open-access journal, it provides invaluable access options for academic institutions and professionals seeking to stay at the forefront of biotechnology innovations. Its commitment to presenting quality research facilitates the growth of knowledge and fosters collaborations across disciplines, making it an essential resource for anyone invested in the rapidly evolving landscape of biosciences.

Microbial Biotechnology, published by WILEY, stands at the forefront of innovation in the field of applied microbiology and biotechnology, showcasing cutting-edge research and advancements within both academic and industrial contexts. As an Open Access journal since 2012, it ensures that high-quality research is easily accessible to researchers, professionals, and students globally, promoting knowledge sharing and collaboration. With an impressive impact, the journal holds a Q1 ranking in its categories—Applied Microbiology and Biotechnology, Biochemistry, Bioengineering, and Biotechnology—demonstrating its significance in the scientific community. The journal currently boasts a strong Scopus ranking in several relevant disciplines, including a top 10% position in Applied Microbiology and Biotechnology, highlighting its critical role in disseminating influential findings. Designed to foster dialogue and advance technology within the microbial sciences, Microbial Biotechnology is an essential resource for anyone committed to leveraging microbial processes for sustainable and innovative solutions.

ENZYME AND MICROBIAL TECHNOLOGY, a premier journal published by Elsevier Science Inc, serves as a pivotal platform for researchers and professionals dedicated to exploring the dynamic intersections of microbiology, biochemistry, and bioengineering. With a rich publication history dating back to 1979 and converging until 2024, this journal has established itself within the Q2 quartile rankings across multiple categories, including Applied Microbiology and Biotechnology, Biochemistry, Bioengineering, and Biotechnology, highlighting its influential role in advancing scientific discourse. It holds impressive Scopus rankings, where it is recognized in the 79th percentile for Applied Microbiology and Biotechnology and ranks favorably in related fields, making it a valuable resource for academic and industrial researchers looking to stay abreast of the latest developments. Although it does not currently offer Open Access options, ENZYME AND MICROBIAL TECHNOLOGY remains an essential read for anyone invested in the biotechnological applications of enzymes and microorganisms.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

Biotecnia is a premier journal published by UNIV SONORA, dedicated to advancing the field of biotechnology through the dissemination of high-quality research and innovative findings. With its ISSN 1665-1456, this journal provides a vital platform for researchers, professionals, and students to share scholarly work that encompasses a diverse range of topics, including molecular biology, genetic engineering, and bioprocessing. Despite being based in Hermosillo, Mexico, Biotecnia’s reach extends globally, aiming to foster collaboration and knowledge exchange among the international scientific community. The absence of an open-access option enhances the journal's exclusivity while ensuring rigorous peer review, thus maintaining high academic standards. As biotechnology continues to play a pivotal role in resolving global challenges, Biotecnia stands as an essential resource for those committed to innovation and research excellence in this evolving discipline.

BIOLOGICAL RESEARCH is a prestigious, peer-reviewed journal published by the Société de Biologie de Chile, dedicated to advancing the fields of Agricultural and Biological Sciences, Biochemistry, Genetics, and Molecular Biology, and Medicine. With an impressive ranking in the top quartile (Q1) in these categories as of 2023, this journal maintains high academic standards and visibility, making it a vital resource for researchers and professionals alike. Operating under an Open Access model since 2013, it ensures that research findings are freely accessible to a global audience, promoting the dissemination of knowledge and collaboration across disciplines. With a publication history dating back to 1992 and continued updates until 2024, BIOLOGICAL RESEARCH serves as a crucial platform for innovative research that impacts both scientific and healthcare communities. The journal’s commitment to quality and relevance is evidenced by its competitive performance in Scopus rankings, further solidifying its role as a leading journal within the biological sciences.